SubscribeLogin
Published

Neuralink Approved for First International Brain Chip Trial - American Faith

Summary by American Faith
Elon Musk’s brain-computer interface (BCI), Neuralink, has been approved by Health Canada to begin its first clinical trial in the country. The trial will be conducted at the University Health Network in Toronto. “We are thrilled to announce that we have received approval from Health Canada to launch the CAN-PRIME Study, our first international trial,” reads a statement from the startup company. “This investigational medical device trial for our…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Elon MuskElon Musk
Health CanadaHealth Canada
NeuralinkNeuralink
CanadaCanada
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal